
Rahul S. Dalal, MD, MPH
@rahulsdalalmd
Gastroenterologist & #IBD specialist @BrighamGI @HarvardMed | #UC pt |📚 MPH @HarvardChanSPH, GI/IBD @BrighamGI, IM @PennMedicine, MD @BrownMedicine, BS @Yale
ID: 1213890301468692480
05-01-2020 18:29:41
166 Tweet
571 Followers
248 Following


How to manage high ostomy output in a patient with #CD & short bowel disease?! #EBMed Excellent presentation by Rahul S. Dalal, MD, MPH Brigham and Women's GI and great discussion by nutrition expert Mount Sinai Division of Gastroenterology Dr Novak on next steps for investigation (including a detailed diet hx) and med rx!



Austin Chiang, MD MPH FASGE FACG Mariam Naveed, MD Maria T. Abreu Carl Kay, MD Romy Chamoun, MD Scrubs & Heels The Bottom Line IBD Anita Afzali MD, MPH, MHCM, FACG, AGAF Tina Aswani-Omprakash, MPH Kelly Issokson MS RD LDN (she/her) American Gastroenterological Association (AGA) Aileen Bui Devika Gandhi, MD Yara Sarkis, MD Abel Joseph @Achintya_singh4 Vibhu Chittajallu, MD, ABOM-D Khushboo Gala Hanna Blaney, MD, MPH Clive Miranda, DO, MSc Rashmi Advani, MD, ABOM ABGH Noa Krugliak Cleveland, MD Noor S. Syed, MD Mouhand Mohamed, MD, MSc Aline Charabaty, MD, FACG, AGAF Patrick Young Joshua M. Steinberg, MD Jumping gene ASGE GI Endoscopy Michelle Baliss, DO Zubair Khan, MD, FACP, CMQ Maia Kayal MD Priscila Santiago, MD Allison Schulman MD, MPH Manik Aggarwal Jorge Machicado, MD, MPH 15- Can’t forget the coveted #DDW2024 Postgraduate Course by American Gastroenterological Association (AGA) x.com/DDWMeeting/sta… @laura_targownik Laura Raffals, MD Peter Higgins Uma Mahadevan Digestive Disease Week Elliot Tapper Jeffrey M Dueker, MD, MPH Amir Ghaffari Brennan Spiegel, MD, MSHS Jonathan Buscaglia, MD Aaron Hecht MD PhD Rahul S. Dalal, MD, MPH

Come check out our #EBGI Tweetorial 🧵on IBD management during 🤰from the most recent PIANO Registry data! 🦪from Dr. Rahul S. Dalal, MD, MPH: 👉continue ustekinumab or vedolizumab during 🤰 ✋worse perinatal outcomes are seen with use of corticosteroids or disease flares‼️ ..more👇

Opioid use nine months after surgery for Crohn's disease onlinelibrary.wiley.com/doi/10.1111/ap… Center for Clinical Epidemiology Bente Mertz Nørgård Ken Lund

Thank you to all of the SPARTAN #GRASpIBD researchers on our multicenter study showing high rates of undiagnosed spondyloarthritis symptoms in IBD Joerg Ermann Rahul S. Dalal, MD, MPH Kristi Kuhn, MD, PhD

Dr Rahul Dalal: comparative effectiveness of tofacitinib vs upadacitinib for ulcerative colitis Rahul S. Dalal, MD, MPH #DDW2024 even after adjusting for severity UPA was 2-3 times more likely to result in steroid free clinical Remisssion David Schwartz

Important data by Rahul S. Dalal, MD, MPH confirming what many of us are seeing in clinical practice - UPA > TOF for UC; in both unadjusted analyses & after inverse prob tx weighting Digestive Disease Week #DDW2024


One-Year Comparative Effectiveness of #Upadacitinib vs Tofacitinib for #UlcerativeColitis AJG - The American Journal of Gastroenterology Brigham and Women's GI Jessica R Allegretti, MD, MPH, FACG, AGAF Edward Barnes MD MPH journals.lww.com/ajg/abstract/9…


Epic downtime = endo playtime Brigham and Women's GI #GIFellows #GIFellowship #GIConsultService #Endoscopy


Is Tramadol better for pain management in IBD patients compared to traditional opioids 💊? Perhaps. doi.org/10.1093/ibd/iz… - Strengths: Nationwide cohort with >50k patients 🇩🇰 - Limitations: Unmeasured confounders, doses unknown Rahul S. Dalal, MD, MPH Sonia Friedman Jessica R Allegretti

IBD Plenary Session at #ACG2024. Jessica R Allegretti, MD, MPH, FACG, AGAF showing Phase 2b results for Anti-TL1A for UC- promising efficacy and safety results. Laurent Peyrin-Biroulet Andres Yarur Silvio Danese Peter Higgins David T. Rubin, MD Anita Afzali MD, MPH, MHCM, FACG, AGAF Elizabeth Paine Aline Charabaty, MD, FACG, AGAF Tauseef Ali MD, FACG AGAF FACP Shrinivas Bishu Parakkal Deepak MD, MS, FACG


Just Jessica R Allegretti, MD, MPH, FACG, AGAF giving bookend oral plenaries at #ACG2024 1. Bezlotoxumab+FMT did not reduce #Cdiff recurrence vs #FMT alone 2. Anti-TL1A therapy appears effective and safe for #UC vs placebo Brigham and Women's GI #IBD #RCT #Biologics



Introducing the Early Career Leadership Program #ECLP 2025 cohort! These GI physicians will complete training in leadership and policy skills and convene with other #ACGInstitute programs at #LeadershipYOU in June 2025. 🎉Congratulations! #ACGfamily #FutureofGI Neena S Abraham MD MACG FASGE AGAF


Predictors for chronic opioid use in patients with inflammatory bowel disease – a population based cohort study in AJG - The American Journal of Gastroenterology journals.lww.com/ajg/abstract/9… In >40,000 #IBD pts, ~25% became chronic #opioid users! Predictors were: 💊prior surgery 💊hypnotic/sedative use 💊age > 50 y

Now published - thank you to all of our co-investigators on this joint effort examining the prevalence and risk factors of SpA symptoms in IBD! Spondylitis.org AJG - The American Journal of Gastroenterology ACG Gastroenterology & Hepatology | NYU Langone Health journals.lww.com/ajg/abstract/9…
